Reimagine your potential
Realise your career aspirations here
We're based in the fabulous Quay Quarter Tower overlooking Sydney harbour. Click below to find out more about working for us.
Pacific Life Re is a leading reinsurer across Australia, with a reputation for offering responsive and tailored services to our partners.
Tyson Johnston
Managing Director | Protection | Australia and Global Strategy
Since opening our Australian office in 2015 we have leveraged our global experience and an enthusiastic team - collectively committed to excellence, innovation and superior service – to build a leadership position in the Australian market.
Our business is built with a clear and informed focus on the future. Utilising a strong foundation of knowledge and expertise, we take new risks as they arise and continue to be driven by a passion to support a sustainable long-term insurance market, building on the hard-fought gains of the industry in recent years.
Working at Pacific Life Re Australia is a rewarding experience with a diverse culture, focus on development, and exposure to a variety of product lines ranging from the traditional industry fund group insurance market through to our unique retail partnership with a life insurance provider.
Our commitment to providing the best solutions available is reinforced by our company's vision to lead the way in technology information. Our underwriting technology, Ocean and UnderwriteMe, not only position us as a leader in the reinsurance industry globally, they put our clients front-and-centre in the crucial decision-making process.
Martyn Gilling
Vice President | Client Solutions | Protection | Australia
Stephen Edwards
Vice President | Pricing | Protection | Australia
Matthew Larkin
Associate Vice President | Client Solutions | Australia
Tony Tong
Managing Vice President | Divisional Business Services |
Asia & Australia
Mark Segreto
Head of Claims | Protection | Australia
Samantha Fjellstad
Associate Vice President | Underwriting | Protection | Australia
Underwriting & Claims
Underwriting processes, practices and philosophies are changing with faster pace than we have ever experienced before.
Medical Advances
A new generation of drugs has now well and truly arrived aiming to improve weight loss. The drugs are heavily touted by celebrities and influencers, despite many of them having no medical need to lose weight. Obesity contributes significantly to some of the most common causes of death including heart disease and cancer, as well as affecting quality of life for millions. In this article we look at these increasingly available drugs offering hope to more people with obesity. We consider their potential to broadly improve health, and their limitations.
Medical Advances
Scientists successfully conducted early-stage trials which provide hope of a future cure for some of the most severe types of multiple sclerosis (MS).
Medical Advances
The world’s largest conference dedicated to the science and treatment of cancer took place in Chicago in early June. The American Society of Clinical Oncology’s annual meeting is a popular forum at which new scientific developments are often revealed.
Medical Advances
A recent review by WHO resulted in reclassification of pituitary adenoma as described in the article
Medical Advances
In 2023 we’ve seen soaring temperatures across the globe along with devastating storms and wildfires. Why is our climate changing and what impact is it having?
Medical Advances
Total deaths from dementias in high-income countries have almost quadrupled in the last 20 years, yet so far medical science has very few answers. This article looks at the recent emergence of the first drugs which may be able to modify the effects of this terrifying disease
Medical Advances
COVID-19 has stolen the limelight from other respiratory viruses in recent years. However there are plenty of other common viruses which can have serious health consequences, among them Respiratory Syncytial Virus, or RSV.
Medical Advances
A new UN report reveals optimism about a possible end to the global AIDS epidemic
Medical Advances
Vaccine technologies have continued to improve greatly in recent years. However, vaccines are little use if people refuse to use them. Here we look at the precarious position of measles, a well-known but little-understood serious condition, which is held in check in most countries only because of high vaccine uptake.
Medical Advances
The International Agency for Research on Cancer (IARC), the cancer research arm of the WHO, recently classified the common sweetener aspartame as a possible cause of cancer in humans.
Protection
Beneath the Surface report 2023 We explored some of the key drivers of sustainability for the protection market. We undertook consumer research which combined with our medical and underwriting expertise and our deep understanding of the market, enabled us to create this report.
Realise your career aspirations here
We're based in the fabulous Quay Quarter Tower overlooking Sydney harbour. Click below to find out more about working for us.